Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11001
CALL
KT
KT
$9.11B
| $103K | ﹤0.01% |
6,700
+5,200
| +347% | +$75K |
|
11002
CALL
Invesco S&P SmallCap Energy ETF
PSCE
$106M
| $103K | ﹤0.01% |
2,100
+2,000
| +2,000% | +$103K |
|
|
NVEE
11003
CALL
DELISTED
NV5 Global
NVEE
| $103K | ﹤0.01% |
4,400
-800
| -15% | -$19K |
|
11004
CALL
Atossa Therapeutics
ATOS
$25.9M
| $103K | ﹤0.01% |
4,507
+1,667
| +59% | +$33.7K |
|
11005
CALL
Atlas Lithium Corp
ATLX
$94.7M
| $103K | ﹤0.01% |
15,100
+2,000
| +15% | +$20.3K |
|
11006
CALL
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.8B
| $103K | ﹤0.01% |
800
+600
| +300% | +$74.1K |
|
11007
CALL
Stagwell
STGW
$2.23B
| $102K | ﹤0.01% |
+14,600
| New | +$100K |
|
11008
PUT
Rigel Pharmaceuticals
RIGL
$795M
| $102K | ﹤0.01% |
6,320
+3,130
| +98% | +$36.8K |
|
|
HTB
11009
CALL
HomeTrust Bancshares
HTB
$834M
| $102K | ﹤0.01% |
+3,000
| New | +$101K |
|
11010
CALL
BARK
BARK
$91.4M
| $102K | ﹤0.01% |
3,135
+760
| +32% | +$24.7K |
|
11011
PUT
Odyssey Marine Exploration
OMEX
$52.9M
| $102K | ﹤0.01% |
123,300
+102,200
| +484% | +$384K |
|
11012
CALL
Bankunited
BKU
$3.44B
| $102K | ﹤0.01% |
2,800
-7,700
| -73% | -$273K |
|
|
HTT
11013
PUT
High Templar Tech Ltd
HTT
$393M
| $102K | ﹤0.01% |
47,900
+46,800
| +4,255% | +$86.5K |
|
|
INCR
11014
Intercure
INCR
$58.6M
| $102K | ﹤0.01% |
50,712
-582
| -1% | -$1.22K |
|
|
UBX
11015
DELISTED
Unity Biotechnology
UBX
| $102K | ﹤0.01% |
69,210
-2,998
| -4% | -$4.4K |
|
|
TOUR
11016
Tuniu
TOUR
$53.2M
| $102K | ﹤0.01% |
7,158
-9,090
| -56% | -$79.1K |
|
11017
PUT
BBVA Argentina
BBAR
$3.13B
| $102K | ﹤0.01% |
9,800
+3,800
| +63% | +$37.3K |
|
|
PCF
11018
High Income Securities Fund
PCF
$102M
| $102K | ﹤0.01% |
+14,877
| New | +$98.9K |
|
11019
CALL
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $102K | ﹤0.01% |
+1,500
| New | +$96.5K |
|
11020
PUT
AMERISAFE
AMSF
$513M
| $101K | ﹤0.01% |
2,100
| – | – |
|
|
JBIO
11021
CALL
Jade Biosciences
JBIO
$1.57B
| $101K | ﹤0.01% |
1,386
+1,069
| +337% | +$69K |
|
11022
CALL
AC Immune
ACIU
$248M
| $101K | ﹤0.01% |
26,800
+13,900
| +108% | +$48.5K |
|
|
AIV
11023
PUT
Aimco
AIV
$383M
| $101K | ﹤0.01% |
11,200
+8,700
| +348% | +$77.3K |
|
11024
CALL
SelectQuote
SLQT
$129M
| $101K | ﹤0.01% |
46,600
+39,500
| +556% | +$130K |
|
11025
HF Foods Group
HFFG
$99.2M
| $101K | ﹤0.01% |
28,319
-38,707
| -58% | -$126K |
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,614 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.